Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:POV-PC)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004389 AN007333 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Feces Pig Environmental stress North Carolina State University LC-MS
ST004389 AN007333 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Milk Pig Environmental stress North Carolina State University LC-MS
ST004350 AN007262 The metabolic effects of succinylation and desuccinylation of HADHB at lysine 292 Cultured cells Rat Nanchang University Second Affiliated Hospital LC-MS
ST004287 AN007127 Lipidomic profiling of PILRAKO xMG in xenotransplant model after mouse microglia(mMg) depletion Microglia Human Alzheimers disease Denali Therapeutics LC-MS
ST004230 AN007041 Effect of ATV:4D9 on Microglial Metabolism and FDG levels in mKate-TREM2/APP mouse model Microglia Mouse Alzheimers disease Denali Therapeutics LC-MS
ST004206 AN006995 Lipidomic Profiling of Sorted Microglia in GPR34-KO/APP-KI Mice Across 4, 8, 16, and 24 Months Glial cells Mouse Neurodegenerative disease Denali Therapeutics LC-MS
ST004205 AN006992 Lipidomic/Metabolomic Characterization of GPR34 KO, WT, TREM2 KO, and GPR34/TREM2 dKO iPSC1-derived microglia Glial cells Human Neurodegenerative disease Denali Therapeutics LC-MS
ST004163 AN006908 Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function Cultured cells Human Metabolic disease Denali Therapeutics LC-MS
ST004163 AN006908 Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function Cultured cells Human Parkinsons disease Denali Therapeutics LC-MS
ST004059 AN006714 Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice Brain Mouse Neurodegenerative disease Denali Therapeutics LC-MS
ST004059 AN006714 Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice Brain Mouse Parkinsons disease Denali Therapeutics LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003736 AN006130 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass (Rumex patientia L.× Rumex tianschanicus A. LOS) Rhizosphere Rumex patientia Hunan Agricultural University LC-MS
ST003501 AN005746 TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism Microglia Mouse Alzheimers disease Denali Therapeutics LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST000608 AN000929 Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies Blood Human Pacific Northwest National Laboratory GC-MS/LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
ST000248 AN000392 Metabolic heterogeneity in Glioblastoma Glioma cells Human Cancer University of Florida LC-MS
  logo